← Leaderboards
Noula Dattu Shembade
University Of Miami School Of Medicine
$4,619,706
Attributed
$5,827,159
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,827,159 · 3
By mechanism
R01$5,827,159 · 3
Top collaborators
- Sabita Roy4 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- William J Harrington$5,964,578
- Omar Adrian Coso$1,100,228
- Wael El-Rifai$24,423,615
- Mary Lou King$4,616,127
- Iliana C Soto$134,738
Others in their field
Other Emerging Leaders on “Acquired Immunodeficiency Syndrome”
- Kimberly Smith · Ppd Development Lp$122,008,792
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Leonard Freedman · Leidos Biomedical Research, Inc.$67,132,816
- Bambra Strokes · Ppd Development Lp$65,000,267
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Carina Remgsamai-Nhe · Fisher Bioservices, Inc.$44,034,909
Research focus
Acquired Immunodeficiency SyndromeVirusInfectionCellsKaposi SarcomaTumorigenesisTumorHuman Herpesvirus 8Mesenchymal Stem CellsIn VivoIn Vivo ModelAffectMolecularMediatingIncidenceHerpesviridae InfectionsIn VitroEnvironmentCancer EtiologyAids Related CancerDesignGenesAntiretroviral TherapyComplex
Grant awards (12)
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis$616,751
R01 · FY2025 · CA · contact PI
Molecular mechanisms governing the ubiquitination signaling during KSHV cell entry and tumorigenesis$507,066
R01 · FY2025 · AI · contact PI
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis$607,897
R01 · FY2024 · CA · contact PI
Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis$452,653
R01 · FY2024 · CA · contact PI
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis$599,301
R01 · FY2023 · CA · contact PI
Molecular mechanisms governing the ubiquitination signaling during KSHV cell entry and tumorigenesis$507,066
R01 · FY2023 · AI · contact PI
Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis$452,653
R01 · FY2023 · CA · contact PI
Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis$61,733
R01 · FY2023 · CA · contact PI
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis$590,958
R01 · FY2022 · CA · contact PI
Molecular mechanisms governing the ubiquitination signaling during KSHV cell entry and tumorigenesis$507,066
R01 · FY2022 · AI · contact PI
Interplay between PDGFRA, oxygen-regulated translation and KSHV in Kaposi's sarcomagenesis$452,653
R01 · FY2022 · CA · contact PI
Molecular mechanisms governing the ubiquitination signaling during KSHV cell entry and tumorigenesis$471,362
R01 · FY2021 · AI · contact PI